SLC7A11 and cancer: In addition to its well-recognized role in orchestrating antitumor immune responses, prior experimental evidence indicates that IFNG can modulate ferroptotic susceptibility by downregulating SLC7A11 expression and enhancing lipid peroxidation in select cancer contexts [35,36].